14 / 18
Page 37
Notes:
J Obes Eat Disord, 2017
ISSN: 2471-8203
August 23-24, 2017 | Toronto, Canada
allied
academies
INTERNATIONAL OBESITY, BARIATRIC AND
METABOLIC SURGERY SUMMIT AND EXPO
Marjan Farshadi, J Obes Eat Disord, 3:2
DOI: 10.21767/2471-8203-C1-002
A
s a chronic disease, non-alcoholic fatty liver disease
(NAFLD) is recognised to be the hepatic manifestation
of obesity and metabolic syndrome, extending from simple
steatosis to more severe nonalcoholic steatohepatitis
(NASH), involving inflammation and apoptosis with or
without fibrosis and cirrhosis. NAFLD is the most frequent
hepatic condition in developed countries and can lead
to steatohepatitis, cirrhosis and even liver cancer. Thus,
managing NAFLD is one of the issues that need to be
considered in the treatment of obesity. The exact mechanism
of the onset and development of NAFLD is not clear although
some possible role players have been identified: oxidative
stress, increased fatty acid syntheses, and inflammation. Up
to the present time, conventional and modern medications
used to treat NAFLD are not adequate and may lead to
serious adverse effects. The perennial herb Curcuma longa
L., with tha common name of Java turmeric, has been used
as a traditional therapeutic plant to decrease the sensitivity
of the liver to lipid peroxidation, as well as beneficial
properties against cancer, abnormally reduced fatty acid
levels, and inflammatory disorders in adipose tissue. Studies
have shown that consuming turmeric supplements improves
serum glucose indices and leptin levels in patients with
NAFLD. Ginger is another dietary supplement that might be
effective in improving NAFLD-related metabolic diseases.
Speaker Biography
Marjan Farshadi has her expertise in science-based natural remedies. After years of
experience in research, natural health, medicine and pharmaceuticals, she established
a research-based company to continue in-depth research and development of natural
health products based on scientific evidences. She is working in Toronto Liver Centre
studying liver diseases, mainly fatty liver disease
e:
marjanfarshadi@yahoo.comPrevention of Non-Alcoholic Fatty Liver Disease (NAFLD) and increasing lipid metabolism
Marjan Farshadi
Toronto Liver Centre, Canada